Najat Khan

Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals, a leader in AI-driven drug discovery. Experienced leader in organic chemistry, computer science, and business.

Best podcasts with Najat Khan

Ranked by the Snipd community

Jan 22, 2025 • 58min

SoftBank Joins OpenAI, Oracle in AI Pact Unveiled by Trump

Rene Haas, CEO of Arm Holdings, discusses the pivotal role of energy-efficient processors in AI infrastructure investments. Rachel Metz shares insights on the collaborations among tech giants like SoftBank and OpenAI, emphasizing the transformative potential of government support in AI. Najat Khan explains how AI is revolutionizing drug discovery, speeding up the path to clinical trials. Ben Harburg analyzes the implications of new investment strategies in China, while Rich Greenfield evaluates Netflix's growth amidst intense streaming competition.

Mar 28, 2025 • 39min

Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44

Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals, dives into the revolutionary impact of AI on drug discovery. She shares insights on how tech-driven biotech firms are transforming the pharmaceutical landscape. The discussion highlights the vital role of AI in clinical development and data integration for better patient outcomes. Exploring challenges and innovations, Najat emphasizes the need for a skilled workforce that bridges science and technology, paving the way for future biotech advancements.